BioCentury | Dec 10, 2007
Company News

Advanced Viral management update

...at Cetek Corp. ; and Dallas Hughes as VP of research, formerly SVP of technology at Cetek Corp. WIR...
BioCentury | Dec 10, 2007
Company News

Advanced Viral deal

...high throughput drug screening technology from Vincent Gullo and Dallas Hughes, the founding scientists of Cetek Corp....
...the deal, Gullo and Hughes will join ADVR as CSO and VP of research, respectively. Cetek...
BioCentury | Jan 9, 2006
Company News

Cetek management update

Cetek Corp. , Marlborough, Mass. Business: High throughput screening Hired: Barry Berkowitz as president and CEO, formerly president and CEO at Scion Pharmaceuticals Inc.; he replaces James Little, who becomes SVP of business development WIR Staff...
BioCentury | Jan 4, 2006
Financial News

Cetek raises $10 million

...Investors included Argonaut ; Ventry Industries; Gainesborough Investments; Cetek Chairman James Waters; and Stata Ventures. Cetek...
BioCentury | Apr 12, 2004
Financial News

Cetek raises $16 million

...High throughput screening company Cetek (Marlborough, Mass.) raised $16 million in a series D round. Investors...
...round. Investors included John and Stephen Davis; Gainsborough Investments; Argonaut Private Equity; and James Waters. Cetek...
BioCentury | Feb 9, 2004
Company News

Cetek management update

Cetek Corp. , Marlborough, Mass. Business: High throughput screening Hired: Vincent Gullo as VP of drug discovery, formerly a senior director at Schering-Plough Research Institute WIR Staff...
BioCentury | Jan 19, 2004
Company News

Scynexis management update

...Hans Fliri as general manager of Scynexis Europe Ltd., formerly VP of drug discovery at Cetek Corp. WIR...
BioCentury | Jan 12, 2004
Company News

Cetek, University of Texas M.D. Anderson Cancer Center deal

...Using Cetek's capillary electrophoresis (CE) assay, the partners will discover and develop small molecule therapeutics isolated...
...and develop small molecule therapeutics isolated from natural extracts to treat cancer and inflammatory diseases. Cetek Corp....
BioCentury | Jan 20, 2003
Company News

Cetek, J&J deal

...The companies renewed a 2001 deal under which Cetek is developing capillary electrophoresis-based screening assays for...
...compound libraries from the institute. Cetek will receive an upfront payment, screening fees and milestones. Cetek Corp....
BioCentury | Aug 26, 2002
Company News

Cetek, Essential deal

...and Cetek’s capillary electrophoresis (CE) assay to identify compounds and natural products with antimicrobial activity. Cetek Corp....
Items per page:
1 - 10 of 42
BioCentury | Dec 10, 2007
Company News

Advanced Viral management update

...at Cetek Corp. ; and Dallas Hughes as VP of research, formerly SVP of technology at Cetek Corp. WIR...
BioCentury | Dec 10, 2007
Company News

Advanced Viral deal

...high throughput drug screening technology from Vincent Gullo and Dallas Hughes, the founding scientists of Cetek Corp....
...the deal, Gullo and Hughes will join ADVR as CSO and VP of research, respectively. Cetek...
BioCentury | Jan 9, 2006
Company News

Cetek management update

Cetek Corp. , Marlborough, Mass. Business: High throughput screening Hired: Barry Berkowitz as president and CEO, formerly president and CEO at Scion Pharmaceuticals Inc.; he replaces James Little, who becomes SVP of business development WIR Staff...
BioCentury | Jan 4, 2006
Financial News

Cetek raises $10 million

...Investors included Argonaut ; Ventry Industries; Gainesborough Investments; Cetek Chairman James Waters; and Stata Ventures. Cetek...
BioCentury | Apr 12, 2004
Financial News

Cetek raises $16 million

...High throughput screening company Cetek (Marlborough, Mass.) raised $16 million in a series D round. Investors...
...round. Investors included John and Stephen Davis; Gainsborough Investments; Argonaut Private Equity; and James Waters. Cetek...
BioCentury | Feb 9, 2004
Company News

Cetek management update

Cetek Corp. , Marlborough, Mass. Business: High throughput screening Hired: Vincent Gullo as VP of drug discovery, formerly a senior director at Schering-Plough Research Institute WIR Staff...
BioCentury | Jan 19, 2004
Company News

Scynexis management update

...Hans Fliri as general manager of Scynexis Europe Ltd., formerly VP of drug discovery at Cetek Corp. WIR...
BioCentury | Jan 12, 2004
Company News

Cetek, University of Texas M.D. Anderson Cancer Center deal

...Using Cetek's capillary electrophoresis (CE) assay, the partners will discover and develop small molecule therapeutics isolated...
...and develop small molecule therapeutics isolated from natural extracts to treat cancer and inflammatory diseases. Cetek Corp....
BioCentury | Jan 20, 2003
Company News

Cetek, J&J deal

...The companies renewed a 2001 deal under which Cetek is developing capillary electrophoresis-based screening assays for...
...compound libraries from the institute. Cetek will receive an upfront payment, screening fees and milestones. Cetek Corp....
BioCentury | Aug 26, 2002
Company News

Cetek, Essential deal

...and Cetek’s capillary electrophoresis (CE) assay to identify compounds and natural products with antimicrobial activity. Cetek Corp....
Items per page:
1 - 10 of 42